Your browser doesn't support javascript.
loading
Subtle Chemical Changes Cross the Boundary between Agonist and Antagonist: New A3 Adenosine Receptor Homology Models and Structural Network Analysis Can Predict This Boundary.
Lee, Yoonji; Hou, Xiyan; Lee, Jin Hee; Nayak, Akshata; Alexander, Varughese; Sharma, Pankaz K; Chang, Hyerim; Phan, Khai; Gao, Zhan-Guo; Jacobson, Kenneth A; Choi, Sun; Jeong, Lak Shin.
Affiliation
  • Lee Y; Global AI Drug Discovery Center, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Hou X; College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
  • Lee JH; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Nayak A; College of Life Science, Dalian Minzu University, Dalian 116600, People's Republic of China.
  • Alexander V; Global AI Drug Discovery Center, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Sharma PK; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Chang H; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Phan K; Global AI Drug Discovery Center, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Gao ZG; Global AI Drug Discovery Center, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Jacobson KA; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Bethesda, Maryland 20892, United States.
  • Choi S; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Bethesda, Maryland 20892, United States.
  • Jeong LS; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Bethesda, Maryland 20892, United States.
J Med Chem ; 64(17): 12525-12536, 2021 09 09.
Article in En | MEDLINE | ID: mdl-34435786
Distinguishing compounds' agonistic or antagonistic behavior would be of great utility for the rational discovery of selective modulators. We synthesized truncated nucleoside derivatives and discovered 6c (Ki = 2.40 nM) as a potent human A3 adenosine receptor (hA3AR) agonist, and subtle chemical modification induced a shift from antagonist to agonist. We elucidated this shift by developing new hA3AR homology models that consider the pharmacological profiles of the ligands. Taken together with molecular dynamics (MD) simulation and three-dimensional (3D) structural network analysis of the receptor-ligand complex, the results indicated that the hydrogen bonding with Thr943.36 and His2727.43 could make a stable interaction between the 3'-amino group with TM3 and TM7, and the corresponding induced-fit effects may play important roles in rendering the agonistic effect. Our results provide a more precise understanding of the compounds' actions at the atomic level and a rationale for the design of new drugs with specific pharmacological profiles.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, Adenosine A3 / Adenosine A3 Receptor Agonists / Adenosine A3 Receptor Antagonists Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, Adenosine A3 / Adenosine A3 Receptor Agonists / Adenosine A3 Receptor Antagonists Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2021 Type: Article